[go: up one dir, main page]

GB202307938D0 - Antigen detection - Google Patents

Antigen detection

Info

Publication number
GB202307938D0
GB202307938D0 GBGB2307938.7A GB202307938A GB202307938D0 GB 202307938 D0 GB202307938 D0 GB 202307938D0 GB 202307938 A GB202307938 A GB 202307938A GB 202307938 D0 GB202307938 D0 GB 202307938D0
Authority
GB
United Kingdom
Prior art keywords
antigen detection
antigen
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2307938.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
QBD QS IP Ltd
AliveDx Suisse SA
Original Assignee
QBD QS IP Ltd
Quotient Suisse SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by QBD QS IP Ltd, Quotient Suisse SA filed Critical QBD QS IP Ltd
Priority to GBGB2307938.7A priority Critical patent/GB202307938D0/en
Publication of GB202307938D0 publication Critical patent/GB202307938D0/en
Priority to CN202480035051.XA priority patent/CN121336112A/en
Priority to AU2024283078A priority patent/AU2024283078A1/en
Priority to PCT/EP2024/064448 priority patent/WO2024245965A1/en
Ceased legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761Hepatitis B
    • G01N33/5764Hepatitis B surface antigen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/082Hepadnaviridae, e.g. hepatitis B virus
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/90Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00Immunoassays for the detection of microorganisms
    • G01N2469/10Detection of antigens from microorganism in sample from host

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
GBGB2307938.7A 2023-05-26 2023-05-26 Antigen detection Ceased GB202307938D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB2307938.7A GB202307938D0 (en) 2023-05-26 2023-05-26 Antigen detection
CN202480035051.XA CN121336112A (en) 2023-05-26 2024-05-24 Antigen detection
AU2024283078A AU2024283078A1 (en) 2023-05-26 2024-05-24 Antigen detection
PCT/EP2024/064448 WO2024245965A1 (en) 2023-05-26 2024-05-24 Antigen detection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2307938.7A GB202307938D0 (en) 2023-05-26 2023-05-26 Antigen detection

Publications (1)

Publication Number Publication Date
GB202307938D0 true GB202307938D0 (en) 2023-07-12

Family

ID=87060949

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2307938.7A Ceased GB202307938D0 (en) 2023-05-26 2023-05-26 Antigen detection

Country Status (4)

Country Link
CN (1) CN121336112A (en)
AU (1) AU2024283078A1 (en)
GB (1) GB202307938D0 (en)
WO (1) WO2024245965A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06013933A (en) * 2004-06-07 2007-01-26 Chiron Corp Rabbit monoclonal antibodies to hepatitis b surface antigens and methods of using the same.
CN101762701A (en) * 2009-06-24 2010-06-30 北京科美东雅生物技术有限公司 Magnetic immunochromatographic strip for detection of hepatitis B surface antigen and preparation method thereof

Also Published As

Publication number Publication date
AU2024283078A1 (en) 2026-01-08
CN121336112A (en) 2026-01-13
WO2024245965A1 (en) 2024-12-05

Similar Documents

Publication Publication Date Title
SI3872091T1 (en) Antibodies against sars-cov-2
ZA202104574B (en) Ship-type-spoofing detection method employing ensemble learning
IL299044A (en) Advanced ransomware detection
SG11202112680XA (en) Rapid aneuploidy detection
GB2596502B (en) Crypto-jacking detection
SG11202113179WA (en) Context detection
GB201915469D0 (en) Cancer detection methods
GB202015115D0 (en) ZIP12 Antibody
GB202105933D0 (en) Anti-IL1rap antibody
GB202307938D0 (en) Antigen detection
GB2591743B8 (en) Analyte detection system
GB201902630D0 (en) Analyte detection method
GB202309981D0 (en) Antibody
GB202110551D0 (en) Fall detection
GB202006306D0 (en) Antibody/antigen detection
GB202208312D0 (en) Presence detection
GB202203260D0 (en) Multi-cancer detection
GB201905237D0 (en) Leak detection
GB2626040B (en) Leak Detection
GB202319511D0 (en) Object detection
GB202313150D0 (en) Detection device
GB202210981D0 (en) Object detection
GB202101700D0 (en) Antibody detection assay
NO346171B1 (en) SARS-CoV-2 DETECTION
GB202014047D0 (en) Sars-cov-2 antibody detection assay

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)